B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 18.48 USD -1.96% Market Closed
Market Cap: 1B USD

Intrinsic Value

The intrinsic value of one BCAX stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.48 USD, Bicara Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BCAX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Bicara Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

BCAX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether BCAX usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BCAX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BCAX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Bicara Therapeutics Inc.

Explain Valuation
Compare BCAX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BCAX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Bicara Therapeutics Inc

Balance Sheet Decomposition
Bicara Therapeutics Inc

Current Assets 297.4m
Cash & Short-Term Investments 290.2m
Other Current Assets 7.2m
Non-Current Assets 127.3m
Long-Term Investments 117.4m
PP&E 2.1m
Other Non-Current Assets 7.8m
Current Liabilities 21m
Accounts Payable 3.7m
Accrued Liabilities 17.4m
Non-Current Liabilities 880k
Other Non-Current Liabilities 880k
Efficiency

Free Cash Flow Analysis
Bicara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bicara Therapeutics Inc

Revenue
0 USD
Operating Expenses
-141.1m USD
Operating Income
-141.1m USD
Other Expenses
19.6m USD
Net Income
-121.5m USD
Fundamental Scores

BCAX Profitability Score
Profitability Due Diligence

Bicara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Bicara Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BCAX Solvency Score
Solvency Due Diligence

Bicara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Bicara Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.22 USD with a low forecast of 11.11 USD and a high forecast of 50.4 USD.

Lowest
Price Target
11.11 USD
40% Downside
Average
Price Target
33.22 USD
80% Upside
Highest
Price Target
50.4 USD
173% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Bicara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BCAX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BCAX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BCAX stock?

The intrinsic value of one BCAX stock under the Base Case scenario is hidden USD.

Is BCAX stock undervalued or overvalued?

Compared to the current market price of 18.48 USD, Bicara Therapeutics Inc is hidden .

Back to Top